CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
Nat Med
; 29(7): 1710-1717, 2023 07.
Article
in En
| MEDLINE
| ID: mdl-37400640
Full text:
1
Database:
MEDLINE
Main subject:
Lymphoma, Large B-Cell, Diffuse
/
Neurotoxicity Syndromes
Type of study:
Etiology_studies
Limits:
Adult
/
Humans
Language:
En
Year:
2023
Type:
Article